US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioAge Labs Inc.

4.19

+0.05001.21%

Post-market: 4.190.00000.00%16:05 EDT

Volume:409.80K

Turnover:1.72M

Market Cap:150.21M

PE:-0.63

High:4.27

Open:4.16

Low:4.16

Close:4.14

Loading ...

Overview Company News Filings

Bioage Labs Announces Company Updates on Apj, Nlrp3, and Platform Programs

THOMSON REUTERS

BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs

Levi & Korsinsky LLP Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline

BioAge Labs, Inc. (BIOA) Loses -67.99% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

BioAge Labs, Inc. (BIOA): A Bull Case Theory

BioAge Stock Advances 14% On Novartis Research Collaboration

BUZZ-BioAge Labs rises on Novartis collaboration for age-related disease drugs

BRIEF-Bioage Labs Announces Multi-Year Collaboration With Novartis To Discover Novel Targets For Therapies That Address Age-Related Diseases And Conditions

BioAge Labs Says it is Partnering With Novartis to Identify Drug Targets to Treat Age-Related Diseases

MT Newswires Live

Bioage Labs Announces Multi-Year Collaboration With Novartis to Discover Novel Targets for Therapies That Address Age-Related Diseases and Conditions

THOMSON REUTERS

Bioage Labs Inc - May Receive up to $530M in Future Milestones

THOMSON REUTERS

Bioage Labs Inc - Novartis to Pay up to $20M in Upfront Payments and Research Funding

THOMSON REUTERS

BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions

Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More

Bioage Labs Inc : Morgan Stanley Cuts to Underweight From Overweight

THOMSON REUTERS

Morgan Stanley Downgrades BioAge Labs to Underweight From Overweight, Slashes Price Target to $5 From $40

MT Newswires Live

BioAge Labs downgraded to Underweight from Overweight at Morgan Stanley

Bioage Labs Falls 76.9% After Jefferies Cuts PT on Co

THOMSON REUTERS

Traders Eye Key Inflation Report as US Equity Futures Waver Pre-Bell

MT Newswires Live

Bioage Labs Cut to Neutral From Buy by Citigroup

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BIOA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIOA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOA\",,,,,undefined,":{"symbol":"BIOA","market":"US","secType":"STK","nameCN":"BioAge Labs Inc.","latestPrice":4.19,"timestamp":1746216000000,"preClose":4.14,"halted":0,"volume":409796,"hourTrading":{"tag":"盘后","latestPrice":4.19,"preClose":4.19,"latestTime":"16:05 EDT","volume":394,"amount":1650.86,"timestamp":1746216312673},"delay":0,"floatShares":23809389,"shares":35850037,"eps":-6.629269,"marketStatus":"Market Closed","change":0.05,"latestTime":"05-02 16:00:00 EDT","open":4.16,"high":4.27,"low":4.16,"amount":1724900.6608,"amplitude":0.02657,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.629269,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1727323200000,"exchange":"NASDAQ","adjPreClose":4.14,"postHourTrading":{"tag":"盘后","latestPrice":4.19,"preClose":4.19,"latestTime":"16:05 EDT","volume":394,"amount":1650.86,"timestamp":1746216312673},"volumeRatio":1.4261532177619143,"impliedVol":0.9044,"impliedVolPercentile":0.7679},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOA\",,,,,undefined,":{"symbol":"BIOA","floatShares":23809389,"roa":"-25.44%","roe":"-50.35%","lyrEps":-6.629269,"volumeRatio":1.4261532177619143,"shares":35850037,"dividePrice":0,"high":4.27,"amplitude":0.02657,"preClose":4.14,"low":4.16,"week52Low":2.88,"pbRate":"0.46","week52High":26.62,"institutionHeld":0,"latestPrice":4.19,"eps":-6.629269,"divideRate":0,"volume":409796,"delay":0,"ttmEps":-6.629269,"open":4.16,"prevYearClose":5.79,"prevWeekClose":4.23,"prevMonthClose":4.2,"prevQuarterClose":3.76,"fiveDayClose":4.23,"twentyDayClose":3.4,"sixtyDayClose":4.62},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIOA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2506160035","title":"Bioage Labs Announces Company Updates on Apj, Nlrp3, and Platform Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2506160035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506160035?lang=en_us&edition=fundamental","pubTime":"2025-01-28 22:06","pubTimestamp":1738073164,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250128:nFWN3OO1G1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2506516755","title":"BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2506516755","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506516755?lang=en_us&edition=fundamental","pubTime":"2025-01-28 22:00","pubTimestamp":1738072800,"startTime":"0","endTime":"0","summary":"Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial Ph1 clinical data anticipated by end of 2025. Expansion of discovery efforts based on insights from BioAge’s platform, including a target identification collaboration with Novartis and a newly announced antibody therapeutics development collaboration with Lilly ExploR&D. RICHMOND, Calif., Jan. 28, 2025  -- BioAge Labs, Inc. , a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced company updates for its programs and platform.Advancement of next-generation APJ agonists with discontinuation of azelaprag. In December, BioAge announced a multi-year research collaboration with Novartis to identify and validate novel therapeutic targets at the intersection of aging biology and exercise, combining BioAge's longitudinal human aging datasets with Novartis expertise in exercise biology. Under the terms of the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioage-labs-announces-company-updates-140000896.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2501778024","title":"Levi & Korsinsky LLP Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2501778024","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501778024?lang=en_us&edition=fundamental","pubTime":"2025-01-08 01:20","pubTimestamp":1736270403,"startTime":"0","endTime":"0","summary":"THE LAWSUIT: This lawsuit is on behalf of all shareholders that purchased stock pursuant and/or traceable to BioAge’s registration statement for th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/levi-korsinsky-llp-notifies-shareholders-of-bioage-labs-inc-bioa-of-a-class-action-lawsuit-and-an-upcoming-deadline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/levi-korsinsky-llp-notifies-shareholders-of-bioage-labs-inc-bioa-of-a-class-action-lawsuit-and-an-upcoming-deadline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2500077974","title":"BioAge Labs, Inc. (BIOA) Loses -67.99% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner","url":"https://stock-news.laohu8.com/highlight/detail?id=2500077974","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500077974?lang=en_us&edition=fundamental","pubTime":"2025-01-02 22:35","pubTimestamp":1735828506,"startTime":"0","endTime":"0","summary":"BioAge Labs, Inc.  has been beaten down lately with too much selling pressure. While the stock has lost 68% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.We use Relative Strength Index , one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.The RSI reading of 27.57 for BIOA is an indication that the heavy selling could be in the process of exhausting itself, so th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioage-labs-inc-bioa-loses-143506211.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4150","BIOA","RSI"],"gpt_icon":0},{"id":"2494386350","title":"BioAge Labs, Inc. (BIOA): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2494386350","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494386350?lang=en_us&edition=fundamental","pubTime":"2024-12-27 22:18","pubTimestamp":1735309111,"startTime":"0","endTime":"0","summary":"We came across abullish thesison BioAge Labs, Inc.  on Value Investing Subreddit Page by value1024. In this article, we will summarize the bulls’ thesis on BIOA. BioAge Labs, Inc. 's share was trading at $5.88 as of Dec 26th.BioAge Labs , a recent IPO in the biotech sector, has experienced significant volatility, dropping 75% from its $20 debut to around $6 last week. Despite the lack of revenue, the company maintains a $220M market cap and boasts over $9 per share in cash, providing runway until 2029. The sharp decline was driven by the termination of a clinical trial for its Azelaprag obesity drug, developed in collaboration with Eli Lilly, leading to investor concerns. However, the market seems to have misunderstood BIOA’s broader potential, as the company is far from a single-drug entity.BioAge Labs, Inc.  is not on our list of the31 Most Popular Stocks Among Hedge Funds. As per our database, 17 hedge fund portfolios held BIOA at the end of the third quarter which was 0 in the prev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioage-labs-inc-bioa-bull-141831408.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TSYW.SI","USAW.SI","NVIW.SI",".IXIC","QLD","BIOA","NQmain","SQQQ","PSQ","QID","TQQQ","MNQmain","BK4007","USJW.SI"],"gpt_icon":1},{"id":"2492187659","title":"BioAge Stock Advances 14% On Novartis Research Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2492187659","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492187659?lang=en_us&edition=fundamental","pubTime":"2024-12-18 23:21","pubTimestamp":1734535260,"startTime":"0","endTime":"0","summary":"BioAge Labs shares rose Wednesday after it said it entered into a research collaboration with the Swiss biopharmaceutical company Novartis, which could earn BioAge up to $550 million.Shares climbed 14% to $4.67, helping to regain some of the 76% loss BioAge experienced on Dec. 6 after it said it was discontinuing a phase-two trial for its obesity treatment.The Richmond, Calif.-based biopharmaceutical company will collaborate on a multi-year research project with Novartis investigating what drives aging-related diseases and the role of physical exercise in longevity. It combines BioAge's human longevity datasets with Novartis's specialty in exercise biology, BioAge said.Under the terms of the agreement, BioAge will receive upfront research funding and payments of up to $20 million, and up to $530 million in future research, development and commercial milestones. BioAge and Novartis both have the right to advance novel targets discovered during the collaboration.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211331839.USD","NVS","IE00B2B36J28.USD","BIOA","IE00BJT1NW94.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4585","BK4578","BK4588","IE0009355771.USD","BK4007","BK4532"],"gpt_icon":0},{"id":"2492182006","title":"BUZZ-BioAge Labs rises on Novartis collaboration for age-related disease drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2492182006","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492182006?lang=en_us&edition=fundamental","pubTime":"2024-12-18 23:19","pubTimestamp":1734535177,"startTime":"0","endTime":"0","summary":"BUZZ-BioAge Labs rises on Novartis collaboration for age-related disease drugs** Drug developer BioAge Labs' BIOA.O shares rise ~10% to $4.52** BIOA says it is collaborating with Swiss drugmaker Novartis NOVN.S to find new drug targets for age-related diseases** BIOA will receive $20 mln upfront and up to $530 mln in milestone payments** Including session's moves, stock down 80% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nL4N3NJ143:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2492603182","title":"BRIEF-Bioage Labs Announces Multi-Year Collaboration With Novartis To Discover Novel Targets For Therapies That Address Age-Related Diseases And Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=2492603182","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492603182?lang=en_us&edition=fundamental","pubTime":"2024-12-18 23:02","pubTimestamp":1734534140,"startTime":"0","endTime":"0","summary":"Dec 18  - BIOAGE Labs Inc   :   * BIOAGE LABS ANNOUNCES MULTI-YEAR COLLABORATION WITH NOVARTIS TO DISCOVER NOVEL TARGETS FOR THERAPIES THAT ADDRESS AGE-RELATED DISEASES AND CONDITIONS   * NOVARTIS TO PAY UP TO $20M IN UPFRONT PAYMENTS AND RESEARCH FUNDING   * MAY RECEIVE UP TO $530M IN FUTURE MILESTONESSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFS","LU1861220207.SGD","UP","LU0106831901.USD","BIOA","LU1668664300.SGD","LU1861217088.USD","BK4008","BK4585","BK4166","BK4588","LU2360107671.USD","LU1791807156.HKD"],"gpt_icon":0},{"id":"2492665184","title":"BioAge Labs Says it is Partnering With Novartis to Identify Drug Targets to Treat Age-Related Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2492665184","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492665184?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:50","pubTimestamp":1734533427,"startTime":"0","endTime":"0","summary":"BioAge Labs  said Wednesday it is teaming up with Novartis  to identify drug targets to treat diseases related to aging.The multiyear research collaboration will use BioAge's human longevity data and platform and Novartis' expertise in physical exercise biology, BioAge said.The company said under the deal, it will get up to $20 million in upfront payments and research funding and may receive up to $530 million in future long-term research, development and commercial milestones.Each company has the right to advance novel targets discovered under the partnership and is eligible to get reciprocal success milestones and tiered royalties, BioAge said.Shares of BioAge jumped nearly 14% and Novartis fell 0.4% in recent Wednesday trading.Price: 4.70, Change: +0.60, Percent Change: +14.63","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0211331839.USD","IE0009355771.USD","BK4532","IE00BJT1NW94.SGD","BK4007","BK4578","BIOA","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4585","NVS","IE00B2B36J28.USD","BK4588","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2492861551","title":"Bioage Labs Announces Multi-Year Collaboration With Novartis to Discover Novel Targets for Therapies That Address Age-Related Diseases and Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=2492861551","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492861551?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:00","pubTimestamp":1734530403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nTUA5T2DHV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2492618627","title":"Bioage Labs Inc - May Receive up to $530M in Future Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2492618627","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492618627?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:00","pubTimestamp":1734530403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nTUA5T2DHV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2492186208","title":"Bioage Labs Inc - Novartis to Pay up to $20M in Upfront Payments and Research Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2492186208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492186208?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:00","pubTimestamp":1734530403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nTUA5T2DHV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2492186225","title":"BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=2492186225","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492186225?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:00","pubTimestamp":1734530400,"startTime":"0","endTime":"0","summary":"Collaboration will leverage BioAge's differentiated human longevity data and platform and Novartis expertise in the biology of physical exercise to identify drug targets to treat diseases related to a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/18/2999089/0/en/BioAge-Labs-Announces-Multi-Year-Collaboration-with-Novartis-to-Discover-Novel-Targets-for-Therapies-that-Address-Age-Related-Diseases-and-Conditions.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4166","LU1861217088.USD","BK4007","BIOA","LU0106831901.USD","LU1861220207.SGD","LU2360107671.USD","DFS","BK4585","LU1668664300.SGD","LU1791807156.HKD"],"gpt_icon":0},{"id":"2490622218","title":"Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2490622218","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490622218?lang=en_us&edition=fundamental","pubTime":"2024-12-11 22:55","pubTimestamp":1733928900,"startTime":"0","endTime":"0","summary":"It was a busy week in the biotech sector with lots of data readouts. This apart, the key regulatory updates and pipeline news also continued to be in the spotlight.BioAge Labs’ BIOA shares plunged after the company announced that it would discontinue the ongoing mid-stage study of its investigational drug candidate, azelaprag.AMT-130 obtained the FDA’s Regenerative Medicine Advanced Therapy  designation to treat Huntington’s disease.The deal was made at an RMAT meeting with the regulatory body in November 2024. The FDA agreed that the reported data from the ongoing early to mid-stage studies of AMT-130 for Huntington’s disease, compared to a natural history external control, are sufficient to serve as the primary basis for a biologics license application  for accelerated approval.Initial results from randomized phase II CRDF-004 demonstrated an objective response rate  of 64% in the 30mg onvansertib dose arm, almost double the 33% ORR observed in the control arm .","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/b7YQi_HTDu1GkQZqPUqgyw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/b7YQi_HTDu1GkQZqPUqgyw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stock-roundup-bioa-down-145500028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LU1829250122.USD","BK4588","BK4139","BK4213","QURE","BIOA","INCY","SOC","BK4585","GSK.UK","BK4532","BK4550","CRDF","GSK"],"gpt_icon":0},{"id":"2490099340","title":"Bioage Labs Inc : Morgan Stanley  Cuts to Underweight From Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2490099340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490099340?lang=en_us&edition=fundamental","pubTime":"2024-12-10 19:31","pubTimestamp":1733830265,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nAZN2SKZV0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2490408096","title":"Morgan Stanley Downgrades BioAge Labs to Underweight From Overweight, Slashes Price Target to $5 From $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2490408096","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490408096?lang=en_us&edition=fundamental","pubTime":"2024-12-10 19:22","pubTimestamp":1733829774,"startTime":"0","endTime":"0","summary":"Morgan Stanley Downgrades BioAge Labs to Underweight From Overweight, Slashes Price Target to $5 From $40","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIOA"],"gpt_icon":0},{"id":"2490098408","title":"BioAge Labs downgraded to Underweight from Overweight at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2490098408","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490098408?lang=en_us&edition=fundamental","pubTime":"2024-12-10 18:30","pubTimestamp":1733826635,"startTime":"0","endTime":"0","summary":"Morgan Stanley downgraded BioAge Labs (BIOA) to Underweight from Overweight with a price target of $5, down from $40. The company discontinued its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-downgraded-to-underweight-from-overweight-at-morgan-stanley?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-downgraded-to-underweight-from-overweight-at-morgan-stanley?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA"],"gpt_icon":0},{"id":"2490733707","title":"Bioage Labs Falls 76.9% After Jefferies Cuts PT on Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2490733707","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490733707?lang=en_us&edition=fundamental","pubTime":"2024-12-09 22:37","pubTimestamp":1733755043,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1EX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2490277757","title":"Traders Eye Key Inflation Report as US Equity Futures Waver Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2490277757","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490277757?lang=en_us&edition=fundamental","pubTime":"2024-12-09 21:47","pubTimestamp":1733752032,"startTime":"0","endTime":"0","summary":"US equity futures were flat before Monday's opening bell with investors' attention focused on the upcoming November consumer price index due for release later in the week.Dow Jones Industrial Average ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DXD","EQR","UDOW","SDOW","QLD","BIOA","TQQQ","BK4187","DJX",".DJI","PSQ",".SPX","QID","BK4585","BK4215","NQmain","BK4007","SQQQ","BK4588","DOG","SATL","MNQmain",".IXIC","DDM"],"gpt_icon":1},{"id":"2490721960","title":"Bioage Labs Cut to Neutral From Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2490721960","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490721960?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:49","pubTimestamp":1733748540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BIOA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 09, 2024 07:49 ET (12:49 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":70,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIOA\",params:#limit:5,,,undefined,":[{"date":"2025-03-20","symbol":"BIOA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":-0.58,"defaultRemindTime":1742500800000,"name":null,"time":"Post Market","dateTimestamp":1742443200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIOA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIOA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0.75,"sell":0.25,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.75,"analysts":4,"updateTime":1740715200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BIOA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BIOA","date":"2025-05-02","current":-2.087206,"percent":0.865772,"low":-14.88445,"twenty":-10.498085,"median":-2.486337,"eighty":-2.155781,"high":-1.532635,"avg":-5.439558,"sd":4.477913,"marketCap":148419153},"quantilePoints":[{"date":"2024-09-27","current":-10.065016,"twenty":-9.996853,"median":-9.894609,"eighty":-9.328936,"marketCap":625601139},{"date":"2024-10-04","current":-11.466752,"twenty":-11.453559,"median":-10.988513,"eighty":-9.962772,"marketCap":712727458},{"date":"2024-10-11","current":-11.290848,"twenty":-11.83725,"median":-11.290848,"eighty":-10.377246,"marketCap":701793959},{"date":"2024-10-18","current":-13.247909,"twenty":-12.852074,"median":-11.505231,"eighty":-10.913754,"marketCap":823437060},{"date":"2024-10-25","current":-13.708907,"twenty":-13.699687,"median":-12.032944,"eighty":-11.062173,"marketCap":852090807},{"date":"2024-10-31","current":-14.198716,"twenty":-13.910593,"median":-12.258321,"eighty":-11.163318,"marketCap":882535413},{"date":"2024-11-08","current":-10.411209,"twenty":-13.841443,"median":-12.631325,"eighty":-11.163318,"marketCap":738550334},{"date":"2024-11-15","current":-9.850761,"twenty":-13.741177,"median":-12.203351,"eighty":-10.879672,"marketCap":698793259},{"date":"2024-11-22","current":-9.318711,"twenty":-13.704297,"median":-11.736106,"eighty":-10.071646,"marketCap":661050728},{"date":"2024-11-29","current":-9.500638,"twenty":-13.685857,"median":-11.456511,"eighty":-9.850761,"marketCap":673956274},{"date":"2024-12-06","current":-9.283336,"twenty":-13.657045,"median":-11.290848,"eighty":-9.500638,"marketCap":658541317},{"date":"2024-12-13","current":-2.319571,"twenty":-13.258776,"median":-11.073716,"eighty":-9.298497,"marketCap":164545707},{"date":"2024-12-20","current":-2.612676,"twenty":-13.247909,"median":-10.411209,"eighty":-9.141838,"marketCap":185337975},{"date":"2024-12-27","current":-2.971476,"twenty":-13.224859,"median":-10.152544,"eighty":-7.606575,"marketCap":210790579},{"date":"2025-01-03","current":-2.809763,"twenty":-13.09117,"median":-10.065016,"eighty":-3.032119,"marketCap":199318983},{"date":"2025-01-10","current":-2.572247,"twenty":-12.858367,"median":-9.894609,"eighty":-2.886577,"marketCap":182470076},{"date":"2025-01-17","current":-2.54698,"twenty":-12.632478,"median":-9.680039,"eighty":-2.714757,"marketCap":180677639},{"date":"2025-01-24","current":-2.678371,"twenty":-12.552115,"median":-9.568861,"eighty":-2.625815,"marketCap":189998311},{"date":"2025-01-31","current":-2.415588,"twenty":-12.247327,"median":-9.318711,"eighty":-2.600547,"marketCap":171356967},{"date":"2025-02-07","current":-2.309464,"twenty":-12.16927,"median":-9.263122,"eighty":-2.51868,"marketCap":163828732},{"date":"2025-02-14","current":-2.284196,"twenty":-12.012055,"median":-9.141838,"eighty":-2.417609,"marketCap":162036295},{"date":"2025-02-21","current":-2.223554,"twenty":-11.928501,"median":-8.818412,"eighty":-2.37516,"marketCap":157734447},{"date":"2025-02-28","current":-2.208393,"twenty":-11.54371,"median":-3.087708,"eighty":-2.319571,"marketCap":156658985},{"date":"2025-03-07","current":-2.269035,"twenty":-11.466752,"median":-2.971476,"eighty":-2.294303,"marketCap":160960833},{"date":"2025-03-14","current":-2.122483,"twenty":-11.446271,"median":-2.893147,"eighty":-2.269035,"marketCap":150564699},{"date":"2025-03-21","current":-2.208204,"twenty":-11.43377,"median":-2.779442,"eighty":-2.233661,"marketCap":157023162},{"date":"2025-03-28","current":-1.956126,"twenty":-11.290848,"median":-2.7188,"eighty":-2.233661,"marketCap":139098143},{"date":"2025-04-04","current":-1.714131,"twenty":-11.203915,"median":-2.693532,"eighty":-2.213447,"marketCap":121890125},{"date":"2025-04-11","current":-1.729255,"twenty":-11.131435,"median":-2.645523,"eighty":-2.198286,"marketCap":122965626},{"date":"2025-04-17","current":-1.890585,"twenty":-11.039085,"median":-2.589935,"eighty":-2.192221,"marketCap":134437638},{"date":"2025-04-25","current":-2.117456,"twenty":-10.879672,"median":-2.54698,"eighty":-2.170997,"marketCap":150570155},{"date":"2025-05-02","current":-2.087206,"twenty":-10.498085,"median":-2.486337,"eighty":-2.155781,"marketCap":148419153}],"updateTime":1746274307130}}}